Statistics and p-values | |||||||||
cCH | eCH | CTRL | cCH vs eCH | cCH vs CTRL | eCH vs CTRL | ||||
Participants | 57 | 48 | 59 | n.a | n.a | n.a | |||
Age (ys; M ± SD) | 45 ± 11 | 46 ± 11 | 44 ± 10 | U = 1243 | 0.42 | U = 1653; | p = 0.88 | U = 1268 | p = 0.355 |
Females/Males | 11/46 | 5/43 | 12/47 | X2 (1,105) = 1.59 | 0.21 | X2 (1,116) = 0.02 | p = 0.89 | X2 (1,107) = 1.95 | p = 0.163 |
Left, right, shifting CH attacks | 20, 29, 8 | 22, 22, 4 | n.a | X2 (1,105) = 0.02 | 0.88 | n.a | n.a | ||
Daily attacks | 3 ± 2 | 2.5 ± 1.6 | n.a | U = 1291 | 0.19 | n.a | n.a | ||
Years of chronic disease (M ± SD) | 8 ± 6.8 | n.a | n.a | n.a | n.a | n.a | n.a | ||
Pts under Lithium | 15 | 4 | n.a | X2 (1,105) = 5.68 | 0.017* | n.a | n.a | ||
Pts under prophylactic treatment | 45 | 17 | n.a | X2 (1,105) = 20.42 | < 0.001* | n.a | n.a | ||
VAS before MRI (Median- range) | 0 (0–3) | 0 (0) | n.a | U = NaN (var. = 0) | n.a | n.a | n.a | ||
cCH (DS1) | cCH (DS2) | Statistics and p-values | eCH ‘in’ | eCH ‘out’ | Statistics and p-values | ||||
Participants | 28 | 29 | n.a | 23 | 25 | ||||
Age (ys; M ± SD) | 45 ± 11 | 45 ± 10 | U = 397 | 0.89 | 51 ± 8 | 42 ± 11 | U = 414 | 0.009* | |
Females/Males | 5/23 | 6/23 | X2 (1,57) = 0.073 | 0.79 | 1/22 | 4/21 | X2 (1, 48) = 1.74 | 0.19 | |
Left, right, shifting CH attacks | 12, 15, 1 | 8, 14, 7 | X2 (1,57) = 0.16 | 0.7 | 9, 13, 1 | 13, 9, 3 | X2 (1, 48) = 2.32 | 0.15 | |
Daily attacks (M ± SD) | 4 ± 2.1 | 2 ± 1.3 | U = 627 | < 0.001* | 2.5 ± 1.9 | 2.4 ± 1.2 (**) | U = 181 | 0.62 | |
Years of chronic disease (M ± SD) | 7 ± 6.2 | 9 ± 7.4 | U = 349 | 0.37 | n.a | n.a | n.a | ||
Pts under Lithium | 11 | 4 | X2 (1, 57) = 4.77 | 0.029* | 4 | 0 | X2 (1, 48) = 4.74 | 0.029* | |
Pts under prophylactic treatment | 24 | 21 | X2 (1, 57) = 1.52 | 0.22 | 16 | 1 | X2 (1, 48) = 22.5 | < 0.001* |